Commonwealth Equity Services LLC boosted its holdings in Vivos Therapeutics, Inc. (NASDAQ:VVOS – Free Report) by 23.8% in the 4th quarter, Holdings Channel reports. The firm owned 26,000 shares of the company’s stock after purchasing an additional 5,000 shares during the period. Commonwealth Equity Services LLC’s holdings in Vivos Therapeutics were worth $112,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Separately, Cutter & CO Brokerage Inc. acquired a new position in Vivos Therapeutics in the 4th quarter valued at $163,000. 26.35% of the stock is owned by institutional investors.
Vivos Therapeutics Trading Down 7.7 %
Shares of Vivos Therapeutics stock opened at $2.29 on Friday. The company has a fifty day moving average price of $3.32 and a 200 day moving average price of $3.55. Vivos Therapeutics, Inc. has a twelve month low of $1.91 and a twelve month high of $6.28. The stock has a market cap of $13.49 million, a price-to-earnings ratio of -0.40 and a beta of 7.31.
Analyst Ratings Changes
Separately, Alliance Global Partners reaffirmed a “buy” rating on shares of Vivos Therapeutics in a report on Tuesday, April 1st.
Read Our Latest Stock Report on Vivos Therapeutics
About Vivos Therapeutics
Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.
Featured Stories
- Five stocks we like better than Vivos Therapeutics
- Best Aerospace Stocks Investing
- Joby Aviation: Operational Momentum vs. Market Sentiment
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Broadcom’s Big Outperformance Shows Strength Amid Tariff Decline
- What is the MACD Indicator and How to Use it in Your Trading
- Carvana: Can Turnaround Strength Outdrive Market Headwinds?
Want to see what other hedge funds are holding VVOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vivos Therapeutics, Inc. (NASDAQ:VVOS – Free Report).
Receive News & Ratings for Vivos Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.